Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 7/20 | 0.54 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.52 |
| ▸ | CLK1 | P49759 | 2/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | ADK | P55263 | 1/20 | 0.42 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.42 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | ABL2 | P42684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31728787 | 0.81 | MAP4K4 (0.51) | MAP4K4LIMK1CLK1KDRADK | |
| SCHEMBL31727760 | 0.78 | MAP4K4 (0.48) | MAP4K4LIMK1CLK1KDRADK | |
| SCHEMBL31727762 | 0.78 | MAP4K4 (0.48) | MAP4K4LIMK1CLK1KDRADK | |
| SCHEMBL31727978 | 0.76 | DHFR (0.51) | MAP4K4LIMK1CLK1KDRDHFR | |
| SCHEMBL31729137 | 0.76 | SRC (0.50) | MAP4K4LIMK1CLK1ALOX5KDR | |
| SCHEMBL31727856 | 0.76 | MAP4K4 (0.53) | MAP4K4LIMK1CLK1KDRFYN | |
| SCHEMBL31728147 | 0.75 | MAP4K4 (0.47) | MAP4K4LIMK1CLK1ALOX5KDR | |
| SCHEMBL31727897 | 0.74 | LIMK1 (0.36) | MAP4K4LIMK1ADK | |
| SCHEMBL31728394 | 0.72 | CLK1 (0.49) | MAP4K4LIMK1CLK1ALOX5KDR | |
| SCHEMBL31728478 | 0.70 | MAP4K4 (0.51) | MAP4K4LIMK1CLK1KDRADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235874-A1 | HETEROCYCLICS AS EGFR INHIBITORS | SCHRÖDINGER, INC. (US) | 2025-11-13 | — | — | WO | disclosed |